Walleye Trading’s Amedisys AMED Stock Holding History

Walleye Trading’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-46,200	Closed	-$4.55M	–	4336
2025 Q2	$4.55M	Buy	46,200 +44,000	+2,000%	+$4.16M	0.01%	1256
2025 Q1	$204K	Sell	2,200 -14,100	-87%	-$1.3M	﹤0.01%	3074
2024 Q4	$1.48M	Sell	16,300 -39,600	-71%	-$3.64M	﹤0.01%	1880
2024 Q3	$5.39M	Sell	55,900 -40,000	-42%	-$3.9M	0.01%	1091
2024 Q2	$8.8M	Buy	95,900 +39,800	+71%	+$3.69M	0.02%	744
2024 Q1	$5.17M	Sell	56,100 -2,000	-3%	-$187K	0.01%	1099
2023 Q4	$5.52M	Buy	58,100 +56,600	+3,773%	+$5.29M	0.01%	1183
2023 Q3	$140K	Hold	1,500	–	–	﹤0.01%	3811
2023 Q2	$137K	Buy	+1,500	New	+$123K	﹤0.01%	3620
2022 Q3	–	Sell	-12,100	Closed	-$1.27M	–	4989
2022 Q2	$1.27M	Buy	+12,100	New	+$1.55M	﹤0.01%	2007
2021 Q3	–	Sell	-300	Closed	-$73K	–	5165
2021 Q2	$73K	Buy	300 +200	+200%	+$52.5K	﹤0.01%	4499
2021 Q1	$26K	Hold	100	–	–	﹤0.01%	4487
2020 Q4	$29K	Sell	100 -1,600	-94%	-$410K	﹤0.01%	4320
2020 Q3	$402K	Sell	1,700 -1,600	-48%	-$364K	﹤0.01%	2428
2020 Q2	$655K	Buy	+3,300	New	+$615K	﹤0.01%	2035
2019 Q4	–	Sell	-8,200	Closed	-$1.07M	–	4206
2019 Q3	$1.07M	Sell	8,200 -2,600	-24%	-$338K	0.01%	1546
2019 Q2	$1.31M	Buy	10,800 +8,500	+370%	+$1.01M	0.01%	1379
2019 Q1	$283K	Sell	2,300 -10,700	-82%	-$1.34M	﹤0.01%	2741
2018 Q4	$1.52M	Sell	13,000 -4,300	-25%	-$507K	0.01%	1298
2018 Q3	$2.16M	Buy	17,300 +1,700	+11%	+$188K	0.01%	1244
2018 Q2	$1.33M	Sell	15,600 -33,200	-68%	-$2.44M	0.01%	1776
2018 Q1	$2.94M	Buy	+48,800	New	+$2.78M	0.02%	871
2017 Q4	–	Sell	-15,500	Closed	-$867	–	4298
2017 Q3	$867	Buy	15,500 +3,200	+26%	+$169K	﹤0.01%	1999
2017 Q2	$773	Buy	12,300 +11,600	+1,657%	+$676K	﹤0.01%	1978
2017 Q1	$36	Sell	700 -4,600	-87%	-$219K	﹤0.01%	3923
2016 Q4	$226K	Buy	5,300 +3,700	+231%	+$157K	﹤0.01%	2705
2016 Q3	$76K	Sell	1,600 -9,600	-86%	-$479K	﹤0.01%	3482
2016 Q2	$564K	Buy	11,200 +5,700	+104%	+$288K	﹤0.01%	2103
2016 Q1	$266K	Buy	5,500 +1,900	+53%	+$73.3K	﹤0.01%	2529
2015 Q4	$143K	Buy	3,600 +900	+33%	+$36K	﹤0.01%	3001
2015 Q3	$102K	Buy	+2,700	New	+$114K	﹤0.01%	2933
2015 Q2	–	Sell	-1,900	Closed	-$51K	–	4786
2015 Q1	$51K	Sell	1,900 -18,500	-91%	-$522K	﹤0.01%	3095
2014 Q4	$600K	Buy	20,400 +19,700	+2,814%	+$486K	0.01%	1429
2014 Q3	$14K	Buy	+700	New	+$13.5K	﹤0.01%	3685
2013 Q4	–	Sell	-8,500	Closed	-$146K	–	3606
2013 Q3	$146K	Buy	+8,500	New	+$126K	﹤0.01%	1839

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Walleye Trading's AMED Position: Q2 2023 in Review

Walleye Trading sold out of Amedisys (AMED) in Q2 2023, closing a stake of 7,814 shares — an estimated $641K sold.

Walleye Trading first reported a position in AMED in Q3 2015 and held it in 18 quarters. The position peaked at $826K in Q4 2018. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

Walleye Trading reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
Walleye Trading sold 7,814 Amedisys shares in Q2 2023, an estimated $641K.
Walleye Trading first reported a position in Amedisys in Q3 2015 and held it in 18 quarters.
Walleye Trading's Amedisys position peaked at $826K in Q4 2018.
301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.